LGND earnings: next report 2026-08-06, real EPS beat/miss history, analyst consensus Buy, P/E 38.81. Updated 2026-07-23.
Ligand Pharmaceuticals (LGND) Research Hub
Ligand Pharmaceuticals (LGND) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 284.47 USD (-1.24%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 38.81, market cap 6.13B. This hub links to the full technical, earnings and options research available for LGND.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 284.47 USD (-1.24%) |
| 52-week range | 245 USD – 323.33 USD |
| Trend regime | Range |
| 14-day RSI | 41.6 (Bearish) |
| Trailing P/E | 38.81 |
| Market cap | 6.13B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for LGND
Covered Call on LGND: how it works, illustrative setup around the real 284.47 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on LGND: how it works, illustrative setup around the real 284.47 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on LGND: how it works, illustrative setup around the real 284.47 USD price, max profit/loss, breakeven and when to use it. Educational.
LGND technical analysis: range, last 284.47 USD, RSI 41.6, 52w range 245 USD–323.33 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is LGND in?
Ligand Pharmaceuticals (LGND) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is LGND in an uptrend or downtrend?
As of 2026-09-11, LGND is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is LGND's trailing P/E ratio?
LGND's trailing P/E is 38.81, with a market cap of 6.13B. See the earnings research page for full valuation detail.
When does LGND next report earnings?
LGND is next scheduled to report earnings on 2026-08-06, with a consensus EPS estimate of 1.84 USD.